Pharmaceutical companies might think it a bit rich being asked to waive the patents on their Covid vaccines by Harry and Meghan, a couple who have rejected the concept of public service in an attempt to monetise their royal status. But let’s overlook the charge of hypocrisy and ask whether there really is any substance to Harry and Meghan’s charge that ‘ultra-wealthy’ pharmaceutical companies are holding up the vaccination of the developing world by refusing to surrender their intellectual property.
Already a subscriber? Log in
Black Friday sale
Subscribe today and get 10 weeks of The Spectator Australia for just $1
- Unlimited access to spectator.com.au and app
- The weekly edition on the Spectator Australia app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Or
Comments
Black Friday sale
Subscribe today and get 10 weeks of The Spectator Australia for just $1
SUBSCRIBEAlready a subscriber? Log in